|
|
|||||||
|
|
|||||||
|
Approval Recommended For Onyx's Carfilzomib
Posted on June 21, 2012 at 14:29 PM EDT
A Food and Drug Administration advisory panel recommended approval for Onyx Pharmaceuticals Inc.'s (Nasdaq: ONXX) multiple myeloma treatment carfilzomib sending the stock price soaring $19.43 to $64.01. Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes. Markets are closed on certain holidays. Stock Market Holiday List By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. Press Release Service provided by PRConnect. Stock quotes supplied by Telekurs USA Postage Rates Bots go here |
|
||||||
|
Copyright Notice |
Privacy Policy |
Information |
Subscriber Services |
Site Map |
RSS
![]() MNG Corporate Site Map | Newspaper Media Kit
|
|||||||
